跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45,233 条关于
“CDK L5 Deficiency Disorder”
全部
45,233
临床试验
39,558
药物
1,264
机构
38
资讯
4,373
去年
Matica Biotechnology Partners with Childs Cure to Develop Gene Therapy for Rare Genetic Disorders
去年
UCB's Fenfluramine Achieves Positive Phase 3 Results in Ultra-Rare CDKL5 Deficiency Disorder
9个月前
UCB's Fenfluramine Shows Significant Seizure Reduction in Phase 3 Trial for CDKL5 Deficiency Disorder
4个月前
Viralgen Partners with Elaaj Bio to Advance Gene Therapy for Rare Pediatric Disorder CDKL5 Deficiency
7个月前
Tenacia Biopharmaceuticals Partners with Golden Age Health to Launch First CDKL5 Deficiency Disorder Treatment in China
去年
China Approves Xuanyuening (Bireociclib): First Dual-Indication CDK Inhibitor for Advanced Breast Cancer
去年
Roche Acquires Regor Therapeutics' CDK Inhibitors for Breast Cancer Treatment
去年
FDA Approves Kebilidi, First Gene Therapy for AADC Deficiency
去年
FDA Approves Kebilidi, First Gene Therapy for AADC Deficiency
去年
FDA Approves Kebilidi, First Gene Therapy Directly Administered to the Brain for AADC Deficiency
第 1 页，共 438 页
上一页
下一页
